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ORIGINAL ARTICLEPersistence of nasal colonization with human pathogenic bacteria and
associated antimicrobial resistance in the German general populationR. Köck1, P. Werner2, A. W. Friedrich3, C. Fegeler2 and K. Becker1, for the Prevalence of Multiresistant Microorganisms (PMM)
Study Group
1 University Hospital Münster, Institute of Medical Microbiology, Münster, 2 University Heilbronn, GECKO Institute of Medicine, Informatics and Economy,
Heilbronn, Germany and 3 University Hospital Groningen, Department for Medical Microbiology and Infection Control, Groningen, The NetherlandsAbstractThe nares represent an important bacterial reservoir for endogenous infections. This study aimed to assess the prevalence of nasal
colonization by different important pathogens, the associated antimicrobial susceptibility and risk factors. We performed a prospective
cohort study among 1878 nonhospitalized volunteers recruited from the general population in Germany. Participants provided nasal
swabs at three time points (each separated by 4–6 months). Staphylococcus aureus, Enterobacteriaceae and important nonfermenters were
cultured and subjected to susceptibility testing. Factors potentially inﬂuencing bacterial colonization patterns were assessed. The overall
prevalence of S. aureus, Enterobacteriaceae and nonfermenters was 41.0, 33.4 and 3.7%, respectively. Thirteen participants (0.7%) were
colonized with methicillin-resistant S. aureus. Enterobacteriaceae were mostly (>99%) susceptible against ciproﬂoxacin and carbapenems
(100%). Extended-spectrum β-lactamase–producing isolates were not detected among Klebsiella oxytoca, Klebsiella pneumoniae and
Escherichia coli. Several lifestyle- and health-related factors (e.g. household size, travel, livestock density of the residential area or
occupational livestock contact, atopic dermatitis, antidepressant or anti-infective drugs) were associated with colonization by different
microorganisms. This study unexpectedly demonstrated high nasal colonization rates with Enterobacteriaceae in the German general
population, but rates of antibiotic resistance were low. Methicillin-resistant S. aureus carriage was rare but highly associated with
occupational livestock contact.
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Study group members are listed in the Appendix.IntroductionMicroorganisms colonizing the human body are involved in
important immunologic processes. They prevent the estab-
lishment of potentially harmful pathogens and assist in
improving the immune system [1]. On the other hand, thew Microbe and New Infect 2016; 9: 24–34
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p://dx.doi.org/10.1016/j.nmni.2015.11.004microbiota may promote the development of allergic diseases
and is a major reservoir for endogenous infections. For bacteria
in the nasal habitat, the latter has mainly been demonstrated for
the role of nasal Staphylococcus aureus carriage in the develop-
ment of nosocomial infections such as bacteraemia, sternal or
orthopaedic infections [2–5].
Recently, noncultural methods have greatly increased
knowledge on the communities of microorganisms colonizing
different body sites [6]. Hence, analyses of 16S rRNA sequences
in samples from the nares of healthy individuals demonstrated
that >80% of rRNA sequences detected belonged to either
Actinobacteria (e.g. cornyebacteria) or Firmicutes (e.g. staphylo-
cocci) [6]. In addition, other bacterial taxa including Proteobac-
teria (e.g. Enterobacteriaceae or Pseudomonales), Bacteriodetes orEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
NMNI Köck et al. Bacterial colonization of the nares 25Fusobacteria were also found [6–8]. Interestingly, various
studies indicated that the composition of the microbiota of
different human habitats is inﬂuenced by several demographic
factors such as gender, age and ethnicity, but also by health-
related factors like hospitalization, intake of antibiotics, anti-
pneumococcal vaccination or presence of viral infections as
well as by lifestyle-associated factors like frequency of hand
washing or smoking [9–13].
Recognizing the value of culture-independent methods, these
techniques have two major limitations. Firstly, they cannot
assess bacterial antibiotic susceptibilities, and secondly, the
overload of information on predominating phyla tends to
dissolve information on the presence of important human
pathogens as a result of the lack of abundance of these species.
However, it is important to overcome these limitations, as
recent studies have indicated changes in the occurrence of
antimicrobial resistant pathogens in the healthy general popu-
lation. This was demonstrated for extended-spectrum β-lacta-
mase (ESBL)- or carbapenemase-producing Enterobacteriaceae
and methicillin-resistant S. aureus (MRSA), which were increas-
ingly found as colonizers of the nares and the intestinal tract in
association with travel activities, contact with or ingestion of
contaminated food items or contact with livestock husbandries
[14–18]. In addition, the emergence of antimicrobial resistant
Gram-negative bacteria among humans has mainly been docu-
mented by studies assessing these pathogens in stool samples or
rectal swabs. Data on their occurrence and persistence in the
nares, which might be important for the probability of trans-
mission to the environment and to other persons, are lacking.
Therefore, the objective of this prospective cohort study
was to assess the occurrence of nasal colonization of important
facultative pathogenic bacteria including S. aureus, Enter-
obacteriaceae and nonfermentative bacteria in samples from a
large number of nonhospitalized volunteers. In addition, infor-
mation on associated antimicrobial resistance and lifestyle
conditions was obtained and correlated with the nasal bacterial
colonization pattern.MethodsNonhospitalized adult participants were recruited in ambula-
tory departments of public health ofﬁces (offering, e.g., travel
vaccination or health checks) or were employees of these of-
ﬁces; dental practices; a family physician’s practice; and among
students at colleges or universities. At the beginning of the
study, participants were informed about the study’s objectives
and provided written informed consent. Ethical approval was
obtained by the ethical commission of the Westphalian
Wilhelms-University Münster (2006-268-f-S).New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiSamples were taken at three different time points (June–
August 2011, January–March 2012, August–October 2012),
each separated by at least 4 months. At every time point,
participants were asked to provide a nasal swab and to answer a
standardized questionnaire. Interviews and nasal swabs were
performed by trained medical or dental students. Answers of
the participants were directly assessed in a protected data-
collection application on a portable USB ﬂash drive.
From all participants, premoistened nasal swabs
(FLOQSwabs™; Copan, Murrieta, CA, USA) were used to
sample the anterior nares. Swabs were immediately transferred
to the microbiologic laboratory. After nonselective enrichment
in Mueller-Hinton broth (24 hours, 36°C), swabs were streaked
onto Columbia blood agar and MacConkey agar as well as ESBL
and S. aureus screening agars (all Oxoid, Wesel, Germany) and
incubated for 24 hours at 36°C. All colonies suspicious for
S. aureus, Enterobacteriaceae or clinically important non-
fermenters (i.e. Acinetobacter baumannii, Pseudomonas spp.,
Achromobacter spp. and Stenotrophomonas spp.) were sub-
cultured on Columbia blood agar.
For species identiﬁcation, all isolates were tested by matrix-
assisted laser desorption/ionization time-of-ﬂight mass spec-
trometry (MALDI-TOF). Antimicrobial susceptibility testing
was performed using Vitek2 automated systems (and for some
nonfermenter species using agar disc diffusion) with clinical
breakpoints and application of expert rules as recommended by
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST). All S. aureus isolates were analysed for the
presence of the nuc and mecA genes [19]. For S. aureus isolates
that were cefoxitin resistant, mecC was tested in addition as
previously described [20].
The questionnaire assessed the following data for each
participant: year of birth, sex, zip code for place of residence,
country of birth, employment in healthcare institutions,
employment with contact to livestock animals, number of other
persons living in the same household, living with companion
animals in the same household, being a smoker, having regular
(i.e. at least weekly) contact with medical personnel, having
regular (i.e. at least weekly) contact with persons with
employment in livestock production, and travelling abroad (if
yes, which countries; within the past 12 months). In addition,
participants were asked whether they had diabetes mellitus,
allergies, chronic skin diseases (e.g. psoriasis, atopic dermatitis,
acne), chronic diseases of the liver or the airways (e.g. asthma,
chronic obstructive pulmonary disease), chronic renal insufﬁ-
ciency, chronic inﬂammatory diseases of the paranasal sinuses
or the bowel, chronic osteomyelitis, solid tumors or haemato-
oncologic diseases. Participants provided information on
whether they were immunocompromised (if yes, why?),
whether they had implanted devices (e.g. heart valves,lf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
TABLE 1. Characteristics of 1878 study participants
Description Category n %
Participation in the cohort study At 1 time point only 427 22.7
At 2 time points 283 15.1
At all 3 time points 1168 62.2
Sex Female 1096 58.4
Male 782 41.6
Age distribution <20 years 107 5.7
21–30 years 387 20.6
31–40 years 240 12.8
41–50 years 423 22.5
51–60 years 384 20.4
61–70 years 163 8.7
71–80 years 132 7.0
81 years 41 2.2
Unknown 1 0.1
Country of birth Germany 1544 82.2
Country other
than Germany
237 12.6
Unknown 97 5.2
Household size 1 person 307 16.4
2 persons 661 35.2
3 persons 366 19.5
4 persons 522 27.8
Unknown 22 1.2
Pets present in household Yes 738 39.3
Employment in healthcare
sector
Yes 205 10.9
Regular contact with medical
personnel
Yes 162 8.6
Occupational direct contact
with livestock or meat
Yes 61 3.2
Regular contact to persons
with livestock-related
employment
Yes 80 4.3
Smoker Yes 560 29.8
Travel abroad No 708 37.7
Other European
countries
1116 59.4
Africa 75 4.0
Asia 70 3.7
Australia 14 0.7
Canada 7 0.4
United States 47 2.5
South or Middle
America
24 1.3
Colonization with Staphylococcus
aureus
At 1 time point onlya 123 of 427 28.8
At 2 time pointsa 120 of 283 42.4
At all 3 time pointsa 525 of 1168 44.9
Totala 768 of 1878 40.9
Colonization with
Enterobacteriaceae
At 1 time point onlya 98 of 427 23.0
At 2 time pointsa 90 of 283 31.8
At all 3 time pointsa 440 of 1168 37.7
Totala 628 of 1878 33.4
Colonization with nonfermenting
pathogen
At 1 time point onlya 3 of 427 0.7
At 2 time pointsa 11 of 283 3.9
At all 3 time pointsa 55 of 1168 4.7
Totala 69 of 1878 3.7
aNasal colonization with (group of) microorganism(s) mentioned in at least one
sample of participant; persons who participated at one time point provided only one
nasal swabs; those who participated at two time points had two swabs; and those
who participated at three times had three swabs.
26 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNIprostheses). Moreover, information on hospitalization (within
the past 12 months) was obtained. Participants were asked
whether they received antibiotics or antimycotic agents (if yes,
oral/intravenous or topical), oral contraceptives or medication
against clinical depression or neuroleptic agents. Data on den-
sity of livestock and human population in different districts as
well as geographical data were assessed from the German
Regional Database (https://www.regionalstatistik.de/; codes
116-33-4, 173-21-4, 449-01-4).
Statistical analysis was performed by SPSS 22 (IBM, Armonk,
NY, USA). Chi-square or Fisher’s exact tests were used toNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licecalculate differences between categorical variable; t test was
used for parametric variables. p <0.05 was considered signiﬁ-
cant. For assessing independent risk factors associated with
nasal colonization of different groups of bacteria, we applied
multivariable logistic regression by stepwise backward selection
of variables and probabilities of 0.05 for entry into and 0.01 for
removal from the model (SPSS 22). All variables associated with
p values of 0.2 were entered into the initial regression model.ResultsOverall, 1878 persons participated in the study. Among these,
1168 (62.2%) participated at all three time points, 283 (15.1%)
at two time points and 427 (22.7%) only once (Table 1). The
majority of participants were female (58.4%), and the median
(mean) age was 45 years (45.1 years) (range, 7–97 years). Fig. 1
shows that all but six of the participants lived in a total of 38
districts in the German federal states of North Rhine–West-
phalia and Lower Saxony.
Of all 1878 participants, 1203 (64.0%) were colonized with
at least one of the bacterial pathogens assessed at least at one
time point. The overall prevalence of nasal S. aureus carriage
was 41.0% (n = 768); 33.4% of the participants were nasally
colonized with Enterobacteriaceae (n = 628) and 3.7% with
nonfermenters (n = 69) (Fig. 2). At the species level, Klebsiella
oxytoca (6.4%), Escherichia coli (6.1%), Proteus mirabilis (6.0%),
Citrobacter koseri (3.6%), Pantoea agglomerans (3.1%), Enter-
obacter aerogenes (2.6%), Klebsiella pneumoniae (2.4%), Cit-
robacter freundii (2.2%), Enterobacter cloacae (1.4%),
Acinetobacter baumannii (1.1%), Raoultella ornithinolytica (1.1%)
and Serratia marcescens (1.0%) were detected in more than 1%
of the 1878 participants. Among those participants carrying
enterobacteria, n = 515 were colonized with one enterobac-
terial species, 96 with two, 16 with three, and one with four
different species, respectively. Of the 69 participants colonized
by nonfermenters, all carried one nonfermentative species only.
Fig. 2 shows a matrix of the frequency of co-colonization.
Statistically signiﬁcant differences in the co-colonization pat-
terns were mainly found for S. aureus carriers, who were less
frequently colonized with various enterobacteria and non-
fermenters (Fig. 3).
Table 2 shows the persistence of nasal colonization as indi-
cated by detection of the bacteria at the three different time
points of investigation. Focusing on those participants who
provided three nasal swabs at time points separated by four to
six months each, the persistence of colonization, which was
ﬁrstly detected at the initial time point of the study, was
signiﬁcantly (p <0.001) different for carriers of S. aureus
(n = 525; 63.8% colonized for more than four months andEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
nses/by-nc-nd/4.0/)
FIG. 1. Places of residence of participants in German federal states of North Rhine–Westphalia and Lower Saxony showing rural and urban districts
and population density (four of overall 1878 participants of study lived outside depicted area).
NMNI Köck et al. Bacterial colonization of the nares 2739.2% for more than eight months), Enterobacteriaceae (n = 440;
54.7% and 32.1%) and nonfermenters (n = 55; 5.5% and 0%).
At the three time points, we obtained a total of 1378
S. aureus isolates (all nuc positive), 1169 Enterobacteriaceae
isolates (from 28 species) and 73 nonfermenter isolates (from
nine species). Enterobacteriaceae mostly belonged to Proteus
mirabilis (n = 211 isolates; 18.0% of all 1168 Enterobacteriaceae
isolates), E. coli (n = 180; 15.4%), K. oxytoca (n = 175; 15.0%),
C. koseri (n = 138; 11.8%), E. aerogenes (n = 86; 7.4%), C. freundii
(n = 64; 5.5%), P. agglomerans (n = 63; 5.4%), K. pneumoniae
(n = 61; 5.2%), E. cloacae, R. ornithinolytica, Hafnia alvei, and
S. marcescens (each n = 27; 2.3%). Among all nonfermenter
isolates, the following species were detected: A. baumannii
(n = 24 isolates; 32.9% of all nonfermenter isolates), Steno-
trophomonas maltophilia (n = 14; 19.2%), Pseudomonas putidaNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access arti(n = 12; 16.4%), Pseudomonas aeruginosa (n = 8; 11.0%), Pseu-
domonas ﬂuorescens (n = 6; 8.2%), Pseudomonas stutzeri (n = 5;
6.8%), Pseudomonas spp. (n = 2; 2.7%), Pseudomonas monteilii
(n = 1; 1.4%) and Achromobacter xylosoxidans (n = 1; 1.4%).
The antibiotic susceptibility test results of every ﬁrst isolate
detected per participant are shown in Table 3; data are shown
for those enterobacterial and nonfermenter species, which
were detected in more than ten participants, respectively.
Resistance against linezolid, vancomycin and tigecyclin was not
detected among S. aureus isolates. Thirteen participants (0.7%)
were colonized with MRSA, as deﬁned by cefoxitin-resistant
isolates harbouring mecA. This represents a proportion of
1.7% MRSA on all 768 S. aureus ﬁrst isolates. In addition,
S. aureus isolates from two participants (0.1%) were cefoxitin
resistant, but neither mecA nor mecC was detectable, andlf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
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FIG. 2. Prevalence of nasal colonization with Staphylococcus aureus, Enterobacteriaceae and nonfermentative bacteria. (A) Prevalence of nasal colo-
nization with S. aureus, Enterobacteriaceae and nonfermentative bacteria among 1878 participants. (B) Total number of participants colonized with
different enterobacterial species. (C) Total number of participants colonized with different nonfermenter species.
28 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNIhyperproduction of β-lactamases was excluded. For these iso-
lates, the mechanism of cefoxitin resistance remained unclear.
Among the enterobacterial species, the Vitek2 ESBL screening
test was negative for all E. coli and Klebsiella spp. isolates. When
testing meropenem, imipenem and ertapenem, all Enter-
obacteriaceae were susceptible. Overall, participants’ ﬁrst iso-
lates of Enterobacteriaceae (all species) were resistant to
ampicillin, cefuroxime, cefotaxime, ciproﬂoxacin, trimetho-
prim–sulfamethoxazole and gentamicin in 67.0, 11.9, 1.6, 0.4,
2.5 and 2.4%, respectively.
Supplementary Tables S1, S2 and S3 show the association
between the risk factors assessed and nasal colonization (at any
time point) with S. aureus, Enterobacteriaceae and non-
fermenters based on univariate analysis and logistic regression.
We found that household sizes of three (odds ratio (OR) 1.420,
95% conﬁdence interval (CI) 1.109–1.818) or more than four
persons (OR 1.349, 95% CI 1.083–1.682), living in regions with
>100 livestock animals per km2 (OR 1.251, 95% CINew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice1.001–1.562), atopic dermatitis (OR 1.706, 95% CI
1.025–2.841) and asthma (OR 1.501, 95% CI 1.015–2.219)
were independently associated with S. aureus carriage, while
female gender (OR 0.752, 95% CI 0.621–0.911), smoking (OR
0.726, 95% CI 0.588–0.896), colonization with Enter-
obacteriaceae (OR 0.644, 95% CI 0.525–0.789) and unreported
household size (OR 0.259, 95% CI 0.075–0.886) were signiﬁ-
cantly less frequent among S. aureus carriers.
Performing a separate analysis for participants colonized with
mecA-positive MRSA showed that only occupational contact
with livestock animals (6/13 vs. 55/1865; p <0.001) and taking
antidepressant/neuroleptic drugs (4/13 vs. 125/1865; p 0.009)
were signiﬁcantly associated with MRSA in univariate analysis. A
regression model initially containing the risk factors associated
with p values of <0.2 revealed that occupational livestock
contact (OR 31.036; 95% CI 8.480–113.585), chronic renal
insufﬁciency (OR 40.611; 95% CI 3.735–441.627), taking anti-
depressant/neuroleptic medication (OR 4.974; 95% CIEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
nses/by-nc-nd/4.0/)
FIG. 3. Nasal co-colonization pattern of Staphylococcus aureus, Enterobacteriaceae and nonfermentative bacteria. Total number of participants colonized
with each of 38 bacteria is indicated at bottom of each column. Colours indicate percentage of participants colonized with respective combination of
microorganisms, except for those cells deﬁned by identical microorganism. In these cells, colours indicate percentage of participants colonized with
respective bacterium only (i.e. without co-colonization). White circles indicate statistically signiﬁcant (p <0.05) differences between participants
colonized with respective species.
NMNI Köck et al. Bacterial colonization of the nares 291.140–21.701) and chronic obstructive pulmonary disease (OR
28.111; 95% CI 1.808–437.103) were independent risk factors
for MRSA.
Nasal colonization with Enterobacteriaceae (Supplementary
Table S2) was associated with age of 71–80 years (OR 1.505,
95% CI 1.00–21.78), travel to the United States (OR 2.022,TABLE 2. Persistence of nasal colonization with Staphylococcus aur
Pathogen/pathogen group Participation ata
Negative at all
time points
S. aureus 1 time point only 304 (71.2)
2 time points 163 (57.6)
3 time points 643 (55.1)
Enterobacteriaceae 1 time point only 329 (77.0)
2 time points 193 (68.2)
3 time points 728 (62.3)
Nonfermenting pathogen 1 time point only 424 (99.3)
2 time points 272 (96.1)
3 time points 1113 (95.3)
NA, not applicable.
aNumber (% per row) of participants in whom colonization with respective group of bacteria w
study.
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access arti95% CI 1.117–3.660) and topical antimycotic therapy (OR
2.933, 95% CI 1.585–5.428). The factors S. aureus carriage (OR
0.671, 95% CI 0.547–0.822), smoking (OR 0.596, 95% CI
0.475–0.748) and hemato-oncologic diseases (OR 0.099, 95%
CI 0.013–0.760), living in regions with low population densities
of <500 inhabitants per km2 (OR 0.739, 95% CI 0.594–0.919)eus, Enterobacteriaceae and nonfermenting pathogens
Positive at
1 time pointa
Positive at
2 time pointsa
Positive at
3 time pointsa Totala
123 (28.8) NA NA 427 (100)
57 (20.1) 63 (22.3) NA 283 (100)
190 (16.3) 129 (11.0) 206 (17.6) 1168 (100)
98 (23.0) NA NA 427 (100)
57 (20.1) 33 (11.7) NA 283 (100)
199 (17.0) 100 (8.6) 141 (12.1) 1168 (100)
3 (0.7) NA NA 427 (100)
11 (3.9) 0 (0) NA 283 (100)
52 (4.5) 3 (0.3) 0 (0) 1168 (100)
as detected stratiﬁed by participation at one, two or three times of participation in the
lf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
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TABLE 3. Antibiotic susceptibilities of Staphylococcus aureus, Enterobacteriaceae and nonfermenting isolates from nasal swabs
Species n
Susceptibility (%)a to:
PEN AMP OXA CXM CTX MER LEV CIP RIF CLI SXT GEN
Staphylococcus aureus 768 35.7 — 98.0 — — — 98.4 — 100 90.0 99.6 98.8
Enterobacteriaceae
Klebsiella oxytoca 121 — — — 98.4 99.2 100 — 100 — — 100 100
Escherichia coli 115 — 80.0 — 98.3 100 100 — 99.1 — — 95.7 98.3
Proteus mirabilis 113 — 85.8 — 99.1 100 100 — 99.1 — — 92.0 98.2
Citrobacter koseri 68 — — 73.5 89.7 100 — 100 — — 100 98.5
Pantoea agglomerans 58 — 69.0 — 91.4 100 100 — 100 — — 100 100
Enterobacter aerogenes 48 — — — 100 100 100 — 100 — — 100 100
Klebsiella pneumoniae 45 — — — 93.3 100 100 — 100 — — 97.8 97.8
Citrobacter freundii 42 — — — 100 100 100 — 100 — — 100 100
Enterobacter cloacae 26 — — — 65.4 100 100 — 100 — — 100 100
Raoultella ornithinolytica 20 — — — 95.0 100 100 — 100 — — 100 100
Serratia marcescens 18 — — — 11.1 100 100 — 100 — — 100 88.9
Hafnia alvei 14 — — — 92.9 100 100 — 100 — — 100 100
Morganella morganii 14 — — — — 71.4 100 — 92.9 — — 92.9 92.9
Serratia liquefaciens 10 — — — — 100 100 — 100 — — 100 10.0
Nonfermenting pathogens
Acinetobacter baumannii 21 — — — — — 100 — 100 — — — 100
Stenotrophomonas maltophilia 14 — — — — — — — 100 — — 100 —
Pseudomonas putida 12 — — — — — 50.0 — 100 — — — 91.7
AMP, ampicillin; CIP, ciproﬂoxacin; CLI, clindamycin; CTX, cefotaxime; CXM, cefuroxime; GEN, gentamicin; LEV, levoﬂoxacin; MER, meropenem; OXA, oxacillin/cefoxitin; PEN,
benzylpenicillin; RIF, rifampicin; SXT, trimethoprim–sulfamethoxazole.
aPercentage of susceptible isolates for the respective antibiotic. On species level, data are shown for those species for which the number of isolates tested was at least ten. Data are
sorted in order of isolates tested for different groups of bacteria. If the same microorganism was isolated more than once from the same participant (at different study time points),
only the ﬁrst isolate was included in the calculation. Intermediate test results are counted as nonsusceptible. A dash indicates that antibiotic was not tested.
30 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNIand with rather low livestock densities of 50–99 animals per
km2 (OR 0.779, 95% CI 0.628–0.966) were signiﬁcantly less
frequent among participants colonized with Enterobacteriaceae.
Carriage of nonfermenters (Supplementary Table S3) was
independently associated with living in areas with a livestock
density of <50 animals per km2 (OR 2.114, 95% CI
1.276–3.504), travel to the United States (OR 3.756, 95% CI
1.418–9.946) and oral antibiotic therapy (OR 1.729, 95% CI
1.018–2.937). For both Enterobacteriaceae and nonfermenters,
the univariate analysis of lifestyle-related risk factors was
repeated for colonization, with each of the different bacterial
species included in these two groups of bacteria as the inde-
pendent variable (Supplementary Table S4).DiscussionIn this prospective study, we assessed nasal colonization with
important human pathogens among a cohort of >1800 in-
dividuals from the general population. Because of the design of
the study, and because the study was carried out in only two
federal states, the participants involved are not fully represen-
tative for the German general population. However, our
approach of recruiting volunteers resulted in the formation of a
sufﬁciently heterogeneous cohort. Comparing the demographic
data assessed with reference data for the German population
(Federal Statistical Ofﬁce of Germany (DESTATIS); https://
www.destatis.de/; data based on 2011–2012 census; date of
data retrieval, 11 September 2014), we can assume that basicNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceparameters such as gender (female; census/cohort: 52%/58%),
mean age (census/cohort: 44 years/45 years) or migration
background (census: 20%; German nationality 91.7%/cohort:
12.6% birth country other than Germany) are comparable.
Also, working in the healthcare sector (10.9% of all partici-
pants), which could signiﬁcantly inﬂuence colonization, was
representative for the German general population, where—
according to DESTATIS data—about 12% of the population
were employed in the healthcare sector in 2011.
Surprisingly, we found that 33.4 and 3.7% of all participants
were colonized with Enterobacteriaceae and nonfermenters,
respectively. Data on studies investigating nasal carriage with
Gram-negative rods are rare because most reports focus on
colonization of the intestinal tract. In Switzerland, Gram-
negative rods (Klebsiella, E. coli, E. cloacae, Citrobacter diversus)
were isolated from nasal samples obtained from 117 (38%) of
534 healthy men [21]. In a cohort of German and Eritrean
children, Enterobacteriaceae were found in 4–8% [22]. In a
recent study on the nasal culturome, more than half of the
number of the individuals harboured isolates belonging to the
Enterobacteriaceae family [23]. For K. pneumoniae, some studies
even showed that colonization rates in the nares or in the
respiratory tract were higher than in stool samples [24]. Hence,
our data support that a major part of the general population is
nasally colonized with Enterobacteriaceae.
Antimicrobial susceptibility testing revealed that among nasal
E. coli, K. pneumoniae and K. oxytoca isolates there was hardly
any resistance against second- (93–98% susceptible) or third-
generation cephalosporins (99–100% susceptible). This ﬁndingEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
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higher proportions according to German national surveillance
data, where cefuroxime/cefotaxime were susceptible in 88.3/
92.4% of E. coli, 81.3/90.8% of K. pneumoniae and 87.5/95.3% of
K. oxytoca isolates (https://ars.rki.de/; reference data for ambu-
latory care, 2013). Moreover, large studies recently indicated
the emergence of resistance against third-generation cephalo-
sporins (associated with ESBL production) in E. coli and Klebsi-
ella isolates obtained from persons in the general population. In
Germany, testing of stool samples from healthy individuals and
outpatients revealed ESBL colonization rates of 4.1–6.3%
[25,26].
Several investigations demonstrated that rectal colonization
with ESBL-producing Enterobacteriaceae was associated with
travel. In the Netherlands, the prevalence of ESBL genes
detected in stool samples of travellers increased from 0 before
to 33.6% after travel (mainly to Southeast Asia) [16]. In a
Scandinavian study, ESBL-producing Enterobacteriaceae were
found in samples from 30% of travellers after return. Risk fac-
tors for ESBL carriage were travel to the Indian subcontinent
(OR 24.8), Asia (OR 8.63) and Northern Africa (OR 4.94) [14].
In addition, among patients colonized with ESBL–E. coli identi-
ﬁed in samples obtained <72 hours after admission to a German
hospital, Asian mother tongue (OR 13.4) was a signiﬁcant risk
factor [27].
As we detected no ESBL production in any of the E. coli, K.
pneumoniae and K. oxytoca isolates tested in this study, we as-
sume a divergent antimicrobial resistance pattern between
Enterobacteriaceae from the nasal and the intestinal habitats with
respect to ESBL-producing organisms. The reasons for this are
unclear, and it is a limitation of this study that it was not
possible to analyse faecal and nasal samples in parallel, which
would have enabled direct comparability of these two reser-
voirs. Hypothetically, the density and variability of enterobac-
terial species in the intestinal tract could facilitate exchange of
resistance determinants. Alternatively, transmission of ESBL-
producing bacteria could predominantly follow orofaecal
transmission pathways, leading to colonization of the intestinal
tract rather than droplet or direct smear infection or cross-
transmission via the hands enabling nasal colonization. Never-
theless, our ﬁndings may have an impact on deﬁning active
surveillance strategies for prevention of infections with multi-
resistant Enterobacteriaceae.
There are only few truly population-based studies on the
prevalence of colonization with S. aureus. In the United
Kingdom, two studies yielded carriage of 23–28% in the general
population [28–31]. This corresponds to investigations from
other countries [30,31]. A review of longitudinal studies found
that about 20% (range 12–30%) of individuals persistently carry
S. aureus, while about 30% are intermittently colonized (rangeNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access arti16–70%), and about 50% (range 16–69%) are noncarriers [5].
Our data mostly conﬁrm these studies. Interestingly, we found
signiﬁcantly lower rates of persistent nasal carriage for Enter-
obacteriaceae and for nonfermenters, although 54.5% of par-
ticipants colonized with Enterobacteriaceae were carriers for
more than 4 and 32.1% for more than 8 months. However, for
drawing more exact conclusions on long-term persistence,
genotyping of all isolates would be necessary in order to
differentiate between repetitive short-term contamination
(with several bacterial clonal lineages) and long-term coloniza-
tion (with one clonal lineage).
Thirteen participants (0.7%) were colonized with mecA-
positive MRSA. Unlike the United States, where the prevalence
of MRSA carriage in the population was estimated to be 1.5% in
2004 [32], MRSA colonization in the German general popula-
tion has rarely been assessed systematically. Various studies
report MRSA carriage at the time of hospital admission to be
about 1.5% [33]. However, these patients already represent a
selected group of people. Interestingly, we detected two par-
ticipants who carried cefoxitin-resistant, nuc-positive S. aureus,
which did not harbour the resistance determinants mecA or
mecC [34]. This might indicate the presence of genetically
divergent yet unknown mec homologues.
Analysis of risk factors conﬁrmed other studies indicating that
S. aureus colonization is more frequent among male subjects
[32,35,36], and some investigators hypothesized that taking
hormonal contraceptives could have a preventive effect [37].
Although the latter risk factor was not signiﬁcantly associated
with S. aureus in our cohort, factors such as larger household
size, atopic dermatitis and asthma were more frequent among
S. aureus carriers compared to other participants, which is in line
with previous investigations [38–41]. We found that smokers
were less frequently carriers of S. aureus, putatively due to the
bactericidal activity of the smoke, which conﬁrms other studies
[42,43]. In addition, we showed that nasal colonization with
Enterobacteriaceae also prevented (OR 0.64) S. aureus carriage,
which was previously described for the competitive effects of
corynebacteria and coagulase-negative staphylococci [44].
The geographic area of this study (as deﬁned by the partic-
ipants’ places of residences) comprises both rural and urban
parts of the German federal states of North Rhine–Westphalia
and Lower Saxony (Fig. 1). The northwestern areas are rep-
resented by a low density of inhabitants and a high density of
livestock (especially pigs). Persons with occupational livestock
contact had a 31 times higher risk for MRSA carriage compared
to the rest of the cohort. It has been shown that livestock-
associated MRSA plays a major role among persons in this
part of Germany, where up to 29% of human MRSA carriers in
hospitals were colonized with MRSA molecular types belonging
to the clonal lineage CC398 as deﬁned by multilocus sequencelf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 24–34
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populations [47]. While the risk of acquiring MRSA CC398 via
direct livestock contact has been demonstrated in various
studies (reviewed in [47]), recent reports from the Netherlands
indicated that MRSA CC398 is increasingly acquired indepen-
dently from livestock exposure by persons in the general
population living in pig-dense regions [48]. In this context, the
results of this study clearly show that this phenomenon does
not affect major parts of the population, as only 0.7% of the
participants were colonized with MRSA.
Taking antidepressant/neuroleptic drugs was another risk
factor for MRSA carriage in this study. An antimicrobial effect of
psychotherapeutic drugs was reported decades ago [49,50].
This raises the question of whether or to what extent phar-
maceutical agents contribute to the selection pressure on
antibiotic-resistant bacteria.
We are not aware of any studies assessing risk factors for
nasal colonization with Enterobacteriaceae or nonfermenters in
the general population. In this study, carriage of both enter-
obacteria and nonfermenters was associated with travel to the
United States. In addition, factors such as topical antimycotic
therapy, age of more than 70 years and oral antibiotic therapy,
as well as certain characteristics of the place of residence had an
impact of colonization with enterobacteria and nonfermenters.
These ﬁndings are unexplained. In contrast, our results that
S. aureus carriage, smoking and hemato-oncologic diseases were
signiﬁcantly less frequent among participants colonized with
Enterobacteriaceae could be due to previous antibiotic con-
sumption, the bactericidal effects of smoking and bacterial
competition in the nasal habitat.
Overall, this prospective cohort study provided insight into
nasal colonization patterns with S. aureus, Enterobacteriaceae
and nonfermenters in the German general population as well as
in associated antimicrobial resistance proﬁles. We demon-
strated frequent and mostly persistent nasal colonization with S.
aureus. However, MRSA carriage was detected in only 0.7% of
the participants. Although colonization rates with Enter-
obacteriaceae were unexpectedly high (overall 33%, with
K. oxytoca, E. coli, Citrobacter spp. and Pantoea spp. being pre-
dominant), antimicrobial resistance of Enterobacteriaceae was
infrequent, and colonization with ESBL-producing Enter-
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